rs114527140

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000585664.5(FKBP10):​c.-23+29G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00203 in 548,408 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0055 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00070 ( 3 hom. )

Consequence

FKBP10
ENST00000585664.5 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.411

Publications

0 publications found
Variant links:
Genes affected
FKBP10 (HGNC:18169): (FKBP prolyl isomerase 10) The protein encoded by this gene belongs to the FKBP-type peptidyl-prolyl cis/trans isomerase (PPIase) family. This protein localizes to the endoplasmic reticulum and acts as a molecular chaperone. Alternatively spliced variants encoding different isoforms have been reported, but their biological validity has not been determined.[provided by RefSeq, Nov 2009]
P3H4 (HGNC:16946): (prolyl 3-hydroxylase family member 4 (inactive)) This nucleolar protein was first characterized because it was an autoantigen in cases on interstitial cystitis. The protein, with a predicted molecular weight of 50 kDa, appears to be localized in the particulate compartment of the interphase nucleolus, with a distribution distinct from that of nucleolar protein B23. During mitosis it is associated with chromosomes. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 17-41812768-G-A is Benign according to our data. Variant chr17-41812768-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 323177.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0055 (836/152012) while in subpopulation AFR AF = 0.0193 (799/41444). AF 95% confidence interval is 0.0182. There are 7 homozygotes in GnomAd4. There are 422 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FKBP10NM_021939.4 linkc.-267G>A upstream_gene_variant ENST00000321562.9 NP_068758.3 Q96AY3-1A0A024R1W3Q8NAG5Q658U4
FKBP10XM_011525099.4 linkc.-267G>A upstream_gene_variant XP_011523401.1
FKBP10XM_011525100.3 linkc.-394G>A upstream_gene_variant XP_011523402.1
FKBP10XM_047436515.1 linkc.-394G>A upstream_gene_variant XP_047292471.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FKBP10ENST00000321562.9 linkc.-267G>A upstream_gene_variant 1 NM_021939.4 ENSP00000317232.4 Q96AY3-1

Frequencies

GnomAD3 genomes
AF:
0.00548
AC:
833
AN:
151894
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00170
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000589
Gnomad OTH
AF:
0.00335
GnomAD4 exome
AF:
0.000701
AC:
278
AN:
396396
Hom.:
3
Cov.:
4
AF XY:
0.000628
AC XY:
132
AN XY:
210072
show subpopulations
African (AFR)
AF:
0.0204
AC:
228
AN:
11158
American (AMR)
AF:
0.000880
AC:
15
AN:
17052
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12098
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25632
South Asian (SAS)
AF:
0.0000888
AC:
4
AN:
45052
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
24170
Middle Eastern (MID)
AF:
0.000577
AC:
1
AN:
1734
European-Non Finnish (NFE)
AF:
0.0000169
AC:
4
AN:
236712
Other (OTH)
AF:
0.00114
AC:
26
AN:
22788
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00550
AC:
836
AN:
152012
Hom.:
7
Cov.:
32
AF XY:
0.00568
AC XY:
422
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.0193
AC:
799
AN:
41444
American (AMR)
AF:
0.00170
AC:
26
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000589
AC:
4
AN:
67960
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
40
80
120
160
200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00441
Hom.:
0
Bravo
AF:
0.00638
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Aug 20, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Osteogenesis imperfecta type 11 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
11
DANN
Benign
0.82
PhyloP100
-0.41
PromoterAI
-0.027
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114527140; hg19: chr17-39969020; API